IHC analysis further underscored this finding, showing reduced proliferation markers Ki67 in the DLL3-suppressed tumors (Figure 5F), collectively indicating that DLL3 downregulation curtails tumor proliferation in vivo. The gene discussed is DLL3; the disease is neoplasm.